Literature DB >> 13475611

Differentiation of group A streptococci with a common R antigen into three serological types, with special reference to the bactericidal test.

R C LANCEFIELD.   

Abstract

In further study of streptococci having the R antigen, the bactericidal test has been used instead of the mouse protection test in investigating the type-specific M antigens of these organisms. The results have been confirmed by M anti-M precipitin tests, and a correlation between the M and T antigens of the strains has been shown. On the basis of a specific M antigen, type 28 has been shown to comprise Griffith's strain Small and four other R-containing strains. A number of other strains previously thought to belong to type 28 on the basis of R antigen reactions have now been identified as belonging either to type 2 or to a new type, designated 48, which shows a one-way cross-relationship to type 13. The bactericidal test is suggested as a useful method for assessing M antigen in group A streptococci and for establishing type-specificity by means of a biological test which is more widely applicable than the standard mouse protection test.

Entities:  

Keywords:  STREPTOCOCCUS/immunology

Mesh:

Substances:

Year:  1957        PMID: 13475611      PMCID: PMC2136803          DOI: 10.1084/jem.106.4.525

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  18 in total

1.  The relationship of M protein and resistance to phagocytosis in the beta hemolytic streptococci.

Authors:  M MORRIS; C V SEASTONE
Journal:  J Bacteriol       Date:  1955-02       Impact factor: 3.490

2.  Studies on immunity to streptococcal infections in man.

Authors:  L W WANNAMAKER; F W DENNY; W D PERRY; A C SIEGEL; C H RAMMELKAMP
Journal:  AMA Am J Dis Child       Date:  1953-09

3.  Occurrence of the M. substance of type 28 group A in streptococci of Lancefield groups B, C and G.

Authors:  W R MAXTED
Journal:  J Gen Microbiol       Date:  1949-01

4.  Streptococcal bacteriostatic antibody in patients treated with penicillin.

Authors:  G DAIKOS; L WEINSTEIN
Journal:  Proc Soc Exp Biol Med       Date:  1951-10

5.  VARIANTS OF HEMOLYTIC STREPTOCOCCI; THEIR RELATION TO TYPE-SPECIFIC SUBSTANCE, VIRULENCE, AND TOXIN.

Authors:  E W Todd; R C Lancefield
Journal:  J Exp Med       Date:  1928-11-30       Impact factor: 14.307

6.  STUDIES ON THE ANTIGENIC COMPOSITION OF GROUP A HEMOLYTIC STREPTOCOCCI : IV. RELATED T BUT DISTINCT M ANTIGENS IN TYPES 15, 17, 19, 23, 30, AND IN TYPES 4, 24, 26, 28, 29, 46. IDENTIFICATION BY SLIDE AGGLUTINATION.

Authors:  W A Stewart; R C Lancefield; A T Wilson; H F Swift
Journal:  J Exp Med       Date:  1944-01-01       Impact factor: 14.307

7.  The ability of group A streptococci killed by heat or mercury arc irradiation to resist ingestion by phagocytes.

Authors:  G G WILEY; A T WILSON
Journal:  J Exp Med       Date:  1956-01-01       Impact factor: 14.307

8.  BACTERIOSTATIC EFFECT OF HUMAN SERA ON GROUP A STREPTOCOCCI : I. TYPE-SPECIFIC ANTIBODIES IN SERA OF PATIENTS CONVALESCING FROM GROUP A STREPTOCOCCAL PHARYNGITIS.

Authors:  S Rothbard
Journal:  J Exp Med       Date:  1945-08-01       Impact factor: 14.307

9.  STUDIES ON THE HEMOLYTIC STREPTOCOCCUS OF HUMAN ORIGIN : II. OBSERVATIONS ON THE PROTECTIVE MECHANISM AGAINST THE VIRULENT VARIANTS.

Authors:  C Lyons; H K Ward
Journal:  J Exp Med       Date:  1935-03-31       Impact factor: 14.307

10.  ANTIGENIC DIFFERENCES BETWEEN MATT HEMOLYTIC STREPTOCOCCI AND THEIR GLOSSY VARIANTS.

Authors:  R C Lancefield; E W Todd
Journal:  J Exp Med       Date:  1928-11-30       Impact factor: 14.307

View more
  141 in total

1.  Strain-specific restriction of the antiphagocytic property of group A streptococcal M proteins.

Authors:  H Kotarsky; A Thern; G Lindahl; U Sjöbring
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

2.  Protective and nonprotective epitopes from amino termini of M proteins from Australian aboriginal isolates and reference strains of group A streptococci.

Authors:  E R Brandt; T Teh; W A Relf; R I Hobb; M F Good
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

3.  Genetic instability of M protein and serum opacity factor of group A streptocci: evidence suggesting extrachromosomal control.

Authors:  P P Cleary; Z Johnson; L Wannamaker
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

4.  Immunogenicity of a 26-valent group A streptococcal vaccine.

Authors:  Mary C Hu; Michael A Walls; Steven D Stroop; Mark A Reddish; Bernard Beall; James B Dale
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

5.  The Delta subunit of RNA polymerase is required for virulence of Streptococcus agalactiae.

Authors:  Amanda L Jones; Rachel H V Needham; Craig E Rubens
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

6.  Agar diffusion studies of group A streptococcal antigens.

Authors:  W A PIERCE
Journal:  J Bacteriol       Date:  1959-06       Impact factor: 3.490

7.  Tissue inhibitor of metalloproteinase 1 activates normal human granulocytes, protects them from apoptosis, and blocks their transmigration during inflammation.

Authors:  Milan Chromek; Kjell Tullus; Joachim Lundahl; Annelie Brauner
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

8.  Homologous and heterologous protection of mice with group A streptococcal M protein vaccines.

Authors:  M K Wittner; E N Fox
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

9.  Protective immunity to the group A Streptococcus may be only strain specific.

Authors:  S A de Malmanche; D R Martin
Journal:  Med Microbiol Immunol       Date:  1994-12       Impact factor: 3.402

10.  The group A streptococcal virR49 gene controls expression of four structural vir regulon genes.

Authors:  A Podbielski; A Flosdorff; J Weber-Heynemann
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.